乳腺癌mRNA疫苗的进展:目前的发展和未来的前景
Wen Zheng1, Wenjie Chen2, Gyorgy Hutvagner1
1School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.
Biochimica et biophysica acta. Reviews on cancer
|December 18, 2025
概括
使者RNA (mRNA) 疫苗通过增强对瘤的免疫反应来治疗乳腺癌的前景. 本综述探讨了mRNA疫苗设计,输送和乳腺癌免疫疗法的临床应用方面的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗学 疫苗学 疫苗学
背景情况:
- 使者RNA (mRNA) 疫苗已经彻底改变了免疫疗法,尤其是COVID-19疫苗.
- 它们在编码瘤抗原方面的灵活性和良好的安全性使得它们成为癌症治疗的前景.
- 乳腺癌亚型通常是"冷"瘤,限制了当前免疫治疗的有效性.
研究的目的:
- 为乳腺癌的mRNA疫苗开发提供全面的审查.
- 专注于抗原选择,mRNA设计和输送策略.
- 讨论临床前和临床发现,工业进步,挑战和未来方向.
主要方法:
- 关于乳腺癌mRNA疫苗的最新科学文献的综述.
- 对临床前和临床研究结果的分析.
- 检查工业发展的进展和挑战.
主要成果:
- mRNA疫苗可以增强抗原呈现和T细胞激活.
- 这些疫苗有可能将免疫学上"冷"的乳腺瘤转化为"热"的瘤.
- 最近的进展显示,乳腺癌mRNA疫苗技术取得了重大进展.
结论:
- mRNA疫苗代表了乳腺癌免疫治疗的非常有前途的平台.
- 需要进一步的研究和开发,以克服临床翻译方面的挑战.
- 伦理考虑和未来的方向对于推进基于mRNA疫苗的疗法至关重要.
更多相关视频
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.1K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.7K
相关概念视频
Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
